| Title of Invention | MORPHOLINE COMPOUND |
|---|---|
| Abstract | A compound represented by the formula (1) wherein ring A is aryl optionally having substituent(s) and the like; ring B is arylene optionally having substituent (s) and the like; m=0-2; n=l-5; X is a bond and the like; Y is a bond and the like; and Z is hydrogen atom and the like or a pharmaceutically acceptable salt thereof, and a hydrate or solvate thereof have affinity for CCR3, and can be pharmaceutical products for the treatment and/or prophylaxis of immune or inflammatory diseases. |
| Full Text |
|---|
1421-CHENP-2007 AFFIDAVIT 04-03-2014.pdf
1421-CHENP-2007 AMENDED CLAIMS 06-05-2014.pdf
1421-CHENP-2007 AMENDED PAGES OF SPECIFICATION 06-05-2014.pdf
1421-CHENP-2007 CORRESPONDENCE OTHERS 16-04-2013.pdf
1421-CHENP-2007 EXAMINATION REPORT REPLY RECEIVED 06-05-2014.pdf
1421-CHENP-2007 FORM-13 27-08-2008.pdf
1421-CHENP-2007 FORM-6 07-05-2008.pdf
1421-CHENP-2007 AMENDED CLAIMS 28-02-2014.pdf
1421-CHENP-2007 AMENDED PAGE OF SPECIFICATION 28-02-2014.pdf
1421-CHENP-2007 CORRESPONDENCE OTHERS 04-03-2014.pdf
1421-CHENP-2007 EXAMINATION REPORT REPLY RECEIVED 28-08-2013.pdf
1421-CHENP-2007 EXAMINATION REPORT REPLY RECEIVED. 28-02-2014.pdf
1421-CHENP-2007 FORM-1 28-02-2014.pdf
1421-CHENP-2007 FORM-13 28-02-2014.pdf
1421-CHENP-2007 FORM-13-1 28-02-2014.pdf
1421-CHENP-2007 FORM-3 28-08-2013.pdf
1421-CHENP-2007 FORM-5 28-02-2014.pdf
1421-CHENP-2007 OTHER PATENT DOCUMENT 28-02-2014.pdf
1421-CHENP-2007 OTHER PATENT DOCUMENT-1 28-02-2014.pdf
1421-CHENP-2007 OTHERS 28-08-2013.pdf
1421-CHENP-2007 POWER OF ATTORNEY 04-03-2014.pdf
1421-CHENP-2007 POWER OF ATTORNEY 28-02-2014.pdf
1421-chenp-2007-correspondnece-others.pdf
1421-chenp-2007-description(complete).pdf
| Patent Number | 260890 | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indian Patent Application Number | 1421/CHENP/2007 | ||||||||||||||||||||||||
| PG Journal Number | 22/2014 | ||||||||||||||||||||||||
| Publication Date | 30-May-2014 | ||||||||||||||||||||||||
| Grant Date | 27-May-2014 | ||||||||||||||||||||||||
| Date of Filing | 05-Apr-2007 | ||||||||||||||||||||||||
| Name of Patentee | MITSUBISHI TANABE PHARMA CORPORATION | ||||||||||||||||||||||||
| Applicant Address | 2-6-18 KITAHAMA CHUO-KU OSAKA-SHI OSAKA 541-8505 | ||||||||||||||||||||||||
Inventors:
|
|||||||||||||||||||||||||
| PCT International Classification Number | C07D 265/30 | ||||||||||||||||||||||||
| PCT International Application Number | PCT/JP2005/017002 | ||||||||||||||||||||||||
| PCT International Filing date | 2005-09-08 | ||||||||||||||||||||||||
PCT Conventions:
|
|||||||||||||||||||||||||